Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Defense was posted on August 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOL

Awarded
SPE2DP26F9056Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--VA Loma Linda FDG
Solicitation # 36C26227Q0133
The Department of Veterans Affairs Loma Linda Healthcare System is conducting a Sources Sought and Request for Information (RFI) to identify qualified sources for a future single-award, Firm Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract. The scope of work involves the procurement of radiopharmaceutical supplies, specifically 18-FDG, F18 NaF, and Bulk F-18 FDG. The intended period of performance consists of a base year starting December 15, 2026, followed by four option years ending December 14, 2031. The government is seeking providers capable of delivering sterile doses for intravenous injection that are compatible with the NMIS System and meet strict quality standards, including a radioactivity variance no greater than plus or minus 20 percent at the time of calibration. Deliveries will be made to the Nuclear Medicine Section at the Loma Linda facility, with routine orders required by the next business day and emergency orders required on the same day. The contractor must be licensed by the State of Operation and the Nuclear Regulatory Commission or an Agreement State Agency, and delivery personnel must be trained in Department of Transportation requirements and radiation safety. Interested parties must submit a capabilities statement, business size representations under NAICS 325412, and SAM.gov entity information to [email hidden] by November 20, 2026. This notice is for planning purposes only and does not constitute a formal solicitation.
262-NETWORK Contract Office 22 (36C262)

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

Show more

Defense Logistics Agency award SPE2DP26F9056, issued on August 19, 2026, is a delivery order under the broader commercial items base admin contract SPE2DX25D9900. The order was awarded to DMS Pharmaceutical Group Inc for the procurement of Lidocaine Hydrochloride Oral Topical Solution, identified by NSN 6505000636197. The specific order consists of 389 units at a unit price of 6.78, resulting in a total contract price of 33.90, with delivery scheduled for September 3, 2026, to Fort Stewart, Georgia. The overarching base contract, SPE2DX25D9900, became effective on April 2, 2025, with a total award value of 19,999,999.00. This administrative contract replaces previous agreement SPE2DX25D9383 and operates under the guidelines of FAR Part 12. The procurement falls under NAICS code 325412 and is managed by the DLA Troop Support Medical Supply Chain within the Department of Defense.

General Info

DLA awarded DMS Pharmaceutical Group 33.90 for Lidocaine solution delivered to Fort Stewart.

Contract Value

$33.9

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2
PDF, High priority: read this firstaward
High
PDF, High priority: read this firsttask-order-award
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F9056 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $33.90 Award Date: 08-19-2026 Delivery order under: SPE2DX25D9900 Line items: - LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOL (NSN/Part 6505000636197, PR 7017973330)

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS